Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H28O8 |
Molecular Weight | 384.4208 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4
InChI
InChIKey=FIHJKUPKCHIPAT-AHIGJZGOSA-N
InChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
651218
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
FDA ORPHAN DRUG |
221206
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
FDA ORPHAN DRUG |
598517
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ATC |
P01BE03
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.3.1 (ART/AMO)
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ATC |
P01BF03
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ATC |
P01BF02
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.3.1
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ATC |
P01BF04
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
WHO-ATC |
P01BF06
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/15/1521
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
FDA ORPHAN DRUG |
693719
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
FDA ORPHAN DRUG |
125599
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
||
|
NCI_THESAURUS |
C277
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
247
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
Artesunate
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
88495-63-0
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
CHEMBL361497
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
6459
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
18346
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000086605
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
DTXSID3042681
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
DB09274
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
m2078
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | Merck Index | ||
|
60W3249T9M
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
63918
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
6917864
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
C73005
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
7458
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
712571
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
PP-05
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
ARTESUNATE
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | Description: A fine, white crystalline powder. Solubility: Very slightly soluble in water; very soluble in dichloromethane R; freely soluble in ethanol (~750 g/l) TS and acetone R. Category: Antimalarial. Storage: Artesunate should be kept in a well-closed container or, if sterile, in a hermetically closed container. It should be protected from light. Labelling: The label states where applicable:? that the substance is free from bacterial endotoxins;? that the substance is sterile. Definition: Artesunate contains not less than 96.0% and not more than 102.0% of artesunate (C19H28O8) using Assay method A, and not less than 98.0% and not more than 102.0% of artesunate (C19H28O8) using Assay method B, both calculated with reference to the anhydrous substance. | ||
|
C039726
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
1042850
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
SUB05576MIG
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY | |||
|
ARTESUNATE
Created by
admin on Fri Dec 15 15:38:51 UTC 2023 , Edited by admin on Fri Dec 15 15:38:51 UTC 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE ACTIVE (PARENT)
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD